Search

Your search keyword '"C. -M. Samama"' showing total 2 results
Start Over Author "C. -M. Samama" Journal transfusion clinique et biologique : journal de la societe francaise de transfusion sanguine
2 results on '"C. -M. Samama"'

1. [Self-sufficiency, needs, prescription and safety of blood products]

Author

G, Folléa, M, Monsellier, A, Grimfeld, B, Pelletier, B, Lassale, P, Morel, C M, Samama, O, Hermine, and J-J, Lefrère

Subjects
Volunteers, Biological Products, Health Services Needs and Demand, Blood Safety, Health Policy, Blood Donors, Europe, Blood, Prescriptions, Blood Banks, Humans, Blood Transfusion, France, Erythrocyte Transfusion
Abstract

The current issues debate will bring together experts around the themes of self-sufficiency (in its national and European aspects) and of needs in cellular blood products. The point of view of the manufacturer and prescribers of blood products will be confronted.

Published
2013

2. [Management of massive bleeding in 2013: seven questions and answers]

Author

A, Godier, C M, Samama, and S, Susen

Subjects
Postpartum Hemorrhage, Disease Management, Fibrinogen, Blood Component Transfusion, Hemorrhage, Factor VIIa, Postoperative Hemorrhage, Combined Modality Therapy, Hemostatics, Recombinant Proteins, Plasma, Tranexamic Acid, Pregnancy, Acute Disease, Humans, Female, Erythrocyte Transfusion
Abstract

The management of massive bleeding has improved, thanks to high-quality blood components and new transfusion strategies. However, it remains controversial and, despite a huge body of literature, randomised control trials are still lacking. However, the therapeutic approach has also evolved, requiring earlier and more active management. If a 'no delay' management is well recognized, its modes are still discussed. Immediate delivery of blood products with ratios close to 1:1:1 for RBC units/fresh frozen plasma/platelet concentrates, through massive transfusion protocol using blood packs, has been advocated, but yet this approach is not evidence-based. Secondly, a targeted strategy to provide fibrinogen concentrates is under evaluation. Tranexamic acid is effective in trauma patients. Recombinant factor VIIa should only be used on a compassionate basis.

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results